Quest Diagnostics (DGX) Tops Q2 EPS by 2c; Reiterates FY Outlook

Go back to Quest Diagnostics (DGX) Tops Q2 EPS by 2c; Reiterates FY Outlook

Quest Diagnostics (DGX) PT Raised to $148 at BofA Securities

July 24, 2020 8:16 AM EDT

BofA Securities analyst Derik de Bruin raised the price target on Quest Diagnostics (NYSE: DGX) to $148.00 (from $142.00) while maintaining a Buy rating.

... More